Ignite Creation Date:
2024-07-17 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06478550
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-06-24
Brief Title:
A Research Study to Understand How People With Type 2 Diabetes Take Ozempic and if the OzempicApp Helps Them Stay on This Treatment
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
A Pilot Study Investigating the Effect of Patient Support Solution App With Connectivity on Once-weekly Semaglutide sc Treatment Persistence in Patients With Type 2 Diabetes in a Clinical Practice Setting
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study looks at how participants with type 2 diabetes take Ozempic and if the Ozempic app helps participants to stay on this treatment Participants will already be prescribed with Ozempic by the study doctor Participants may be asked to use a device called Mallya which participants must attach to their Ozempic injection pen Participants might also be asked to install an Ozempic app on their mobile phone which supports the participants in the use of Ozempic At the beginning and at the end of this study the participants will have to fill out some questionnaires about their diabetes treatment Participants may also be chosen to participate in a voluntary non-mandatory interview after the study has ended The total duration of study is approximately 10 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U1111-1286-4221 | OTHER | None | None |